PUBLIC CONTROL SIGNAL LABS · 10 MINUTES

Assess regulatory control evidence
across the globe.

Choose a country or jurisdiction, trace each control to its public source, record the evidence you can show, and receive a gate-based decision signal with lane-level coverage and next actions. Singapore, UAE and Australia are available now; more country routes can be added to the same workflow.

Select an option to open its control-evidence lab below.
SingaporeRNX-SIG-SG-01 · Control evidence and source traceDubai / UAERNX-SIG-UAE-01 · Route, virtual-asset and trade signalsAustraliaRNX-SIG-AU-01 · AML/CTF and resilience lanes
Use this safely

Do not enter customer names, account numbers, transaction details, personal data or confidential documents. This is an independent browser-based review aid. It is not produced, approved, endorsed, authorised or certified by MAS, VARA, DFSA, CBUAE, AUSTRAC, APRA, ASIC or any government authority.

HOW IT WORKS

A result you can use in the next meeting.

Each answer updates a traceable control row. The primary result is a decision gate; lane coverage is shown only as supporting context.

01

Choose the route

Select Singapore, UAE mainland/VARA or DIFC/DFSA, or Australia. ADGM/FSRA remains a separate route.

02

Record the evidence

For each control test, select Meets, Partial, Does not meet, Not assessed or Not applicable. Record only non-sensitive references.

03

Assess the signal

Press Assess this matrix after completing every applicable status. The control result, risk gate and action then appear together.

04

Take the actions

Use the gaps, lane signals and official source links in your internal review. Results remain in this browser unless you export them.

PLAIN-LANGUAGE GUIDE

The key terms, in one minute.

These short definitions help first-time users read the source matrix. They are orientation only; the linked primary sources remain the authority for scope and interpretation.

TBML

Trade-based money laundering

Moving or disguising value through trade by manipulating price, quantity, description, documents or counterparties.

PF

Proliferation financing

Funding the development, acquisition or transfer of weapons of mass destruction or related delivery systems.

CDD

Customer due diligence

Identifying and verifying the customer and beneficial owner, understanding the relationship and applying ongoing review where required.

FEAT

Responsible-AI principles

Fairness, Ethics, Accountability and Transparency—the four principles used in the MAS responsible-AI reference path.

COSMIC

Financial-crime information sharing

Singapore’s secure financial-crime information-sharing platform and related public reference materials; this tool is not a replacement for it.

Scope note: This page uses regulator and law names only to identify public source paths. It is not produced, approved, endorsed, authorised or certified by any named authority.

SIGNAL DECISION LOGIC

Critical controls override the aggregate indicator.

The coverage indicator is secondary. The primary result is a source-derived control gate, with a separate lane view so a strong area cannot hide a material gap elsewhere.

BLOCKEDA critical control is Does not meet or Not assessed. Escalate and remediate before relying on the process.
CONDITIONALA critical control is Partial, or the route is incomplete. Assign an owner and target date.
REMEDIATEA non-critical control is open or partially evidenced. Review the control design and add evidence.
REVIEWABLEAll applicable critical controls are evidenced and no open control remains. This is not certification.
SIGNAL LABS

Open a jurisdiction-specific signal.

These calculations are an independent review method derived from the source-to-control matrix below. They are not percentages prescribed by a regulator.

1 Select route→2 Record evidence→3 Assess→4 Export or remediate
SINGAPORE · INDEPENDENT REVIEW AID RNX-SIG-SG-01

Singapore control evidence lab

Trace AI governance, AML/CFT, beneficial ownership, trade-risk escalation and controlled information-sharing evidence to their public source paths.

8 SOURCE ROWS · 8 TESTS
SOURCE TRACE MATRIX

What the signal is actually testing

Source rows identify the public reference; control tests state the question; evidence tests state what can be shown; result and risk are outputs.

8 SOURCE ROWS · 8 CONTROL TESTS
MAS FEAT / AI governance referenceResponsible-AI reference · independent evidence path
AI use-case owner and human reviewDefine the decision, owner, affected people, materiality and override path.
EvidenceUse-case inventory, owner, risk classification, human-review and override records.
ResultAwaiting assessment
RiskNot rated
MAS Technology Risk GuidelinesGuideline · technology and third-party risk
Technology, model and vendor accountabilityKeep cloud, vendor, incident and model-change responsibility visible.
EvidenceVendor register, responsibility map, change control, incident process and review date.
ResultAwaiting assessment
RiskNot rated
MAS Notice 626Notice · AML/CFT risk assessment and mitigation
ML/TF risk assessment and mitigationIdentify, assess and mitigate customer, product, delivery and geographic risk.
EvidenceApproved risk assessment, mitigation plan, review trigger and accountable owner.
ResultAwaiting assessment
RiskNot rated
MAS Notice 626 + GuidelinesNotice/guidance · customer due diligence
Beneficial ownership and legal personsIdentify and verify ownership/control, then manage opaque or layered structures.
EvidenceOwnership map, verification source, refresh trigger and escalation trail.
ResultAwaiting assessment
RiskNot rated
MAS Notice 626 + financial-crime guidanceNotice/guidance · transaction and trade risk
TBML, PF and suspicious-activity escalationDetect multiple red flags and escalate with rationale, ownership and records.
EvidenceTrade-document review, red-flag library, threshold, rationale and decision owner.
ResultAwaiting assessment
RiskNot rated
MAS Notice 656Notice · single counterparty group exposures
Large-exposure concentration controlsTest whether exposure measurement, aggregation, limits and escalation for a single counterparty group are governed and evidenced.
EvidenceExposure aggregation methodology, limit monitoring, exception/escalation records and management review.
ResultAwaiting assessment
RiskNot rated
MAS Notice 637Notice · risk-based capital adequacy
Capital adequacy and risk-weighted exposure governanceTest whether capital-ratio calculation, risk-weighted exposures, leverage and ICAAP-related governance are supported by traceable controls and evidence.
EvidenceCapital calculations, reconciliation/validation records, ICAAP documentation, approvals and regulatory disclosures.
ResultAwaiting assessment
RiskNot rated
MAS FSM-N02 / COSMIC materialsInformation-sharing · internal governance
Confidential information-sharing governanceControl access, referral rationale, confidentiality, retention and auditability.
EvidenceApproval procedure, safeguards, records, access review and audit trail.
ResultAwaiting assessment
RiskNot rated
Signal rule: each row is scored independently. A critical Does not meet or Not assessed row is Critical; a critical Partial row is High. “Meets” records reported evidence; it does not verify the evidence or establish compliance.
OFFICIAL SOURCE PATHS
Verify the current source before relying on a signal.Each source row below maps to one or more of these public references. Links open the regulator’s publication page; no paragraph-level legal conclusion is implied.
PRUDENTIAL LEARNING REFERENCES
Large exposures and capital adequacyFor learning and control-review purposes, keep the historical 2018 Large Exposures consultation distinct from current requirements. MAS currently lists Notice 656 for exposures to single counterparty groups and Notice 637 for risk-based capital adequacy.
REVIEW METADATA
Keep the assessment accountableRecord references, ownership and limitations only. Do not upload customer data or confidential evidence.
LOCAL-ONLY FIELDS
SYNTHETIC SAMPLE CASE
Singapore bank using AI for AML monitoring

Illustrative only: ownership refresh is incomplete, while AI governance and information-sharing evidence are available. No customer data is used.

01

AI use-case owner and human review

Evidence to look for: inventory, owner, decision purpose, affected people, risk classification and override path.

02

AI quality, explainability and oversight

Evidence to look for: data-quality checks, fairness review, explainability, override/escalation path and post-change monitoring.

03

Technology and third-party accountability

Evidence to look for: vendor register, cloud responsibilities, change control, incident process, service-level expectations and review dates.

04

Risk assessment and beneficial ownership

Evidence to look for: approved risk assessment, ownership/control map, verification source, refresh trigger and escalation for opaque structures.

05

TBML, PF and suspicious-activity escalation

Evidence to look for: trade-document review, red-flag library, escalation threshold, case rationale and human decision owner.

06

Confidential information-sharing governance

Evidence to look for: confidentiality rules, access approval, referral rationale, safeguards, retention and audit trail.

Complete all control statuses, then press Assess this matrix.
PUBLIC / INTERNAL BOUNDARY

Useful in public. Governed in private.

This page is for early-stage review, training, workshop preparation and evidence-gap discussion. A bank or regulated institution would need its own approved methodology, current source validation, authorised access, secure evidence handling, audit trail and qualified human review before relying on an output.

Public tool can doTrace source-derived controls, calculate lane coverage, apply decision gates, highlight open gaps and create a short action summary.
Public tool cannot doMake a legal conclusion, file a report, replace a regulator platform, screen live customers or certify compliance.
Keep internalCustomer data, transaction evidence, case files, regulator correspondence, model-validation records and board decisions.
REFERENCE PATHS

Check the current source before relying on a result.

These links are starting points for source verification. Regulatory content, effective dates and scope can change.

Last reviewed: 27 September 2026 · Independent review-support tool · Not official regulatory instruction.